Yes. Found Health (joinfound.com) is a legitimate GLP-1 telehealth platform. Found uses US-licensed clinicians, FDA-regulated 503A sterile compounding pharmacies, and complies with state telehealth prescribing laws. The semaglutide and tirzepatide they prescribe use the same active pharmaceutical molecules as Wegovy, Ozempic, Zepbound, and Mounjaro — the same clinical evidence base applies. Found is not a scam.
The honest follow-up: Found has genuine limitations worth understanding before enrolling — primarily around pharmacy transparency (pharmacy not publicly named for independent verification), promotional first-month pricing that increases significantly after month one, and dose-tier pricing at maintenance. These are service model limitations, not legitimacy concerns.
The Legitimacy Checklist: What Makes a GLP-1 Telehealth Platform Safe
Before evaluating Found specifically, it helps to know what criteria actually determine whether a GLP-1 telehealth provider is legitimate and safe. These are the five factors that matter clinically and regulatorily.
What "Illegitimate" Actually Looks Like — And Why Found Isn't That
Red Flags of Illegitimate GLP-1 Providers
Found's Genuine Limitations — What You Should Know Before Enrolling
Legitimacy and optimal value are different questions. Found is legitimate; the following are service model limitations that matter for making an informed enrollment decision, not safety concerns.
Promotional first-month pricing
Found frequently advertises a promotional first-month rate (~$99) that is significantly lower than their ongoing subscription rate (~$169–$269/month depending on plan and dose tier). Patients who see the promotional rate and enroll without checking the ongoing rate can be surprised when their second month's charge is nearly double the promotional amount. Verify the ongoing monthly rate — not the promotional rate — before enrolling. Ask specifically: "What is the monthly rate starting from month two, and does it change with dose?"
Compounding pharmacy not publicly named
Found does not prominently disclose which specific compounding pharmacy prepares their GLP-1 medications. For patients who want to verify the pharmacy's state board license independently before enrolling — which is a reasonable request for an injectable medication — this information is not readily accessible on Found's public-facing materials. Contact Found support and ask for the pharmacy's name and state board license number. They should be able to provide this.
Dose-tier pricing at maintenance
Found's pricing is dose-dependent — as your GLP-1 dose increases through the titration schedule, the monthly cost increases. The promotional first-month rate and initial-dose pricing don't reflect what you'll pay at maintenance doses. Understand the full pricing structure across the typical titration timeline (starting dose through 72 weeks) before committing.
Found vs Luma Health: Verified Comparison
| Factor | Found Health | Luma Health |
|---|---|---|
| Is it legitimate? | ✓ Yes — US-licensed clinicians, 503A pharmacies | ✓ Yes — Wasef Health, PC; VialsRX TX#35264 |
| First-month promotional rate | ~$99 promo → $169–$269/mo ongoing | $197/mo flat — no promo that resets |
| Ongoing sema rate (maintenance) | ~$179–$269/mo | $197/mo flat |
| Pharmacy named publicly | Not prominently — ask support | ✓ VialsRX, TX #35264 — verify before payment |
| Coaching included | ✓ Yes — health coaching in subscription | Not included |
| Tirzepatide available | ✓ ~$199–$249/mo | ✓ $297/mo flat |
| Contracts | Varies — verify before enrolling | None — cancel anytime |
| 50-state availability | ✓ All 50 states | ✓ All 50 states |
Frequently Asked Questions
Is Found Health a scam?
No. Found Health is a legitimate GLP-1 telehealth platform, not a scam. They use US-licensed clinicians, FDA-regulated 503A compounding pharmacies, and comply with state telehealth prescribing laws. The semaglutide and tirzepatide they prescribe use the same active pharmaceutical molecules as FDA-approved brand-name drugs. Patient complaints about Found are typically about service model issues — promotional pricing that increases after month one, dose-tier pricing, and pharmacy transparency — not about safety or legitimacy.
Is Found FDA-approved for weight loss?
Found is not itself FDA-approved — no telehealth platform receives FDA approval as a platform. What matters is whether Found prescribes FDA-regulated medications through FDA-regulated pharmacies. The compounded semaglutide and tirzepatide that Found's licensed clinicians prescribe use active pharmaceutical ingredients that are FDA-approved in brand-name drugs (Wegovy, Ozempic, Zepbound, Mounjaro). The pharmacies that prepare Found's compounded formulations are licensed 503A sterile compounding pharmacies regulated by state pharmacy boards and USP <797> sterile compounding standards. This is the correct regulatory framework for compounded GLP-1 telehealth.
Why is Found's second-month price higher than the first month?
Found frequently offers promotional first-month pricing (~$99) to reduce the barrier to enrollment. The ongoing monthly rate — which applies from the second month forward — is significantly higher (~$169–$269/month depending on your plan and dose tier). This promotional pricing structure is a sales and marketing approach, not unique to Found (many subscription services use it), but it creates a pricing surprise for patients who enroll based on the promoted rate without checking the ongoing cost. Before enrolling with Found, confirm the exact ongoing monthly rate and the pricing schedule as your dose increases through titration.
Does Found use a real pharmacy for GLP-1?
Yes. Found uses FDA-regulated 503A sterile compounding pharmacies to prepare their semaglutide and tirzepatide formulations. These pharmacies operate under state pharmacy board oversight and USP <797> sterile compounding standards — the same regulatory framework used by all legitimate compounded GLP-1 platforms. Found does not publicly name its specific pharmacy partner(s) in consumer-facing materials. If you want to independently verify Found's pharmacy before enrolling, contact Found support and ask for the pharmacy's name and state board license number. For comparison, Luma Health publicly names VialsRX (TX State Board license #35264) — verifiable at pharmacy.texas.gov before payment.
How does Found compare to Luma Health?
Both are legitimate GLP-1 telehealth platforms. The primary differences: Found includes health coaching in the subscription (a genuine value-add for patients who use it consistently) while Luma Health does not. Found has a promotional first-month rate that increases significantly after month one; Luma Health charges $197/month flat from the start with no promotional rate hike. Found doesn't prominently name its compounding pharmacy; Luma Health names VialsRX (TX #35264) publicly. At maintenance doses, Found's pricing (~$179–$269/mo) is higher than Luma Health's flat $197/mo for some patients. If you consistently engage with weight loss coaching, Found's value proposition is stronger. If you primarily want predictable flat-rate medication access with a publicly named pharmacy, Luma Health is the cleaner fit.
What should I verify before enrolling with any GLP-1 telehealth provider?
Five things to verify before giving any GLP-1 telehealth provider payment information: (1) Confirm a licensed clinician conducts your medical evaluation — not automated approval. (2) Ask for the specific compounding pharmacy name and state board license number — legitimate providers can provide this; verify the license at the state pharmacy board website. (3) Confirm the ongoing monthly rate after any promotional period — ask specifically what month two and month twelve pricing is at the expected maintenance dose. (4) Understand the cancellation policy — whether there's a commitment period, how to cancel, and what the process is for written cancellation confirmation. (5) Verify the provider is operating in your state with a clinician licensed in your state of residence. All of these apply whether evaluating Found, Luma Health, or any other GLP-1 telehealth platform.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed
- FDA. Human Drug Compounding — Section 503A. FDA.gov
- FDA. BeSafeRx — Online Pharmacy Verification. FDA.gov
- Found Health. Official Website. joinfound.com
- Texas State Board of Pharmacy. License Verification. pharmacy.texas.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov